Chief Business Officer
Current3io Therapeutics is a Toronto-based biotechnology company focused on the development and commercialisation of the next generation of viral immunotherapies for cancer
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Ben W. is listed as CBO at 3io Therapeutics / CBO at Selentus Science at 3io Therapeutics, based in Hong Kong SAR, United States, United States. AeroLeads shows a matched LinkedIn profile for Ben W..
Ben W. previously worked as Chief Business Officer at 3Io Therapeutics and Chief Business Officer at Selentus Science Limited. Ben W. holds Dbl Ma (Hons), Chinese & Japanese from The University Of Edinburgh.
This section adds company-level context without repeating Ben W.'s masked contact details.
Review company-level records connected to Ben W. before choosing the right outreach path.
Bio-pharma investment, business development, licensing, M&A, strategic consulting, China/Asia business development, primary market research, Mandarin fluency
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Toronto, Ontario, CA
3io Therapeutics is a Toronto-based biotechnology company focused on the development and commercialisation of the next generation of viral immunotherapies for cancer
Responsible for business development. Selentus develops innovative haemostatic technologies for better surgical outcomes. Selentus is developing a pipeline of products based on its unique technology platform that offer high performance, low cost manufacture and avoid the use of blood-derived materials. Selentus' lead product, TenaTac®, was approved for.
Toronto, ON, CA
Responsible for business development, investment origination and evaluation, and strategic and operational planning of a new investment firm focused on facilitating the global development and commercialization of high-potential life science innovations originating from Canada, China, South Korea, and other markets that represent a significant source of.
Operated under the name Walker-Nichols Ltd. from 2005 to 2009
Quick answers generated from the profile data available on this page.
Ben W. works for 3io Therapeutics.
Ben W. is listed as CBO at 3io Therapeutics / CBO at Selentus Science at 3io Therapeutics.
Ben W. is based in Hong Kong SAR, United States, United States while working with 3io Therapeutics.
Ben W. has worked for 3Io Therapeutics, Selentus Science Limited, Novatio Ventures, Nexanova Ltd., and Convoy Therapeutics.
You can use AeroLeads to view verified contact signals for Ben W. at 3io Therapeutics, including work email, phone, and LinkedIn data when available.
Ben W. holds Dbl Ma (Hons), Chinese & Japanese from The University Of Edinburgh.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts